At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 29, 2026 at 20:00 ET
Four insiders at United Therapeutics sold a combined $1.18 million in stock over a one-week window, including notable open-market sales by the CEO, CFO, general counsel, and a director. The transactions follow a pattern of routine option exercises and tax-related disposals, with the largest sale coming from a director.
- CEO Martine Rothblatt sold 65 shares for $36K on 2026-04-02 and gifted 698,384 shares in non-cash transactions on 2026-04-01
- CFO James Edgemon sold 120 shares for $66K and exercised options for 10,000 shares at $135.42
- General Counsel Paul Mahon sold 514 shares for $288K and exercised options for 8,300 shares at $146.03
- Director Christopher Causey sold 1,300 shares for $786K on 2026-03-30 at $604.64 per share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access